Philippe Bougnoux

Université de Tours FR

0000-0002-8717-055X

241

Publications

9,191

Citations

H-Index

127

i10-Index

7.0

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers

C. Abrial, M. Mouret-Reynier, S. Amat, I. Sillet-Bach, P. Bougnoux - Medical Oncology, 2005

Cited by 8 Semantic Scholar

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer OA

J. Bonneterre, Véronique Diéras, M. Tubiana‐Hulin, P. Bougnoux, M. Bonneterre - British Journal of Cancer, 2004

Cited by 67 Semantic Scholar

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate OA

S. Amat, P. Bougnoux, Frédérique Penault-Llorca, F. Fétissof, H. Curé - British Journal of Cancer, 2003

Cited by 99 Semantic Scholar

Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial OA

Marc Spielmann, M. Tubiana-Hulin, Moïse Namer, H. mansouri, P. Bougnoux - British Journal of Cancer, 2002

Cited by 19 Semantic Scholar

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.

B. Chauvet, A. Reynaud-Bougnoux, G. Calais, Nicolas Panel, Jacques Lansac - International Journal of Radiation Oncology, Biology, Physics, 1990

Cited by 62 Semantic Scholar

Carcinoma of the uterine cervix stage IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy.

G. Calais, O. le Floch, B. Chauvet, A. Reynaud-Bougnoux, P. Bougnoux - International Journal of Radiation Oncology, Biology, Physics, 1989

Cited by 37 Semantic Scholar

Research Topics

Fatty Acid Research and Health (69) Cancer, Lipids, and Metabolism (57) Cancer Treatment and Pharmacology (37) Breast Cancer Treatment Studies (33) HER2/EGFR in Cancer Research (23)

Affiliations

Université Claude Bernard Lyon 1

FR 2004 - 2004

Université de Tours

FR 2024 - 1994

Université d'Orléans

FR 1994 - 1994

Université Européenne de Bretagne

FR 2013 - 2013

Centre National de la Recherche Scientifique

FR 2013 - 1989

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers

Philippe Bougnoux

Publication & Citation Trends

Publications

Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer OA

Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate OA

Sequential or alternating administration of docetaxel (Taxotere®) combined with FEC in metastatic breast cancer: a randomised phase II trial OA

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.

Carcinoma of the uterine cervix stage IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy.

Research Topics

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back